# Bommier C, Maurer MJ, Lambert J. What clinicians should know about surrogate end points in hematologic malignancies. Blood. 2024;144(1):11–20. DOI: 10.1182/blood.2023022269
# Bommier C, Maurer MJ, Lambert J. What clinicians should know about surrogate end points in hematologic malignancies. Blood. 2024;144(1):11–20. DOI: 10.1182/blood.2023022269
# Bommier C, Maurer MJ, Lambert J. What clinicians should know about surrogate end points in hematologic malignancies. Blood. 2024;144(1):11–20. DOI: 10.1182/blood.2023022269
# Bommier C, Maurer MJ, Lambert J. What clinicians should know about surrogate end points in hematologic malignancies. Blood. 2024;144(1):11–20. DOI: 10.1182/blood.2023022269
# Bommier C, Maurer MJ, Lambert J. What clinicians should know about surrogate end points in hematologic malignancies. Blood. 2024;144(1):11–20. DOI: 10.1182/blood.2023022269
# Bommier C, Maurer MJ, Lambert J. What clinicians should know about surrogate end points in hematologic malignancies. Blood. 2024;144(1):11–20. DOI: 10.1182/blood.2023022269
# Bommier C, Maurer MJ, Lambert J. What clinicians should know about surrogate end points in hematologic malignancies. Blood. 2024;144(1):11–20. DOI: 10.1182/blood.2023022269
# Bommier C, Maurer MJ, Lambert J. What clinicians should know about surrogate end points in hematologic malignancies. Blood. 2024;144(1):11–20. DOI: 10.1182/blood.2023022269